ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
tinyteddy
|
62 |
17K |
2 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
62
|
17K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
tinyteddy
|
62 |
17K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
tinyteddy
|
62 |
17K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
tinyteddy
|
161 |
54K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
161
|
54K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
tinyteddy
|
161 |
54K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
161
|
54K
|
0
|
|
ASX - By Stock
|
D2O |
Re:
Price target $1.78
|
|
tinyteddy
|
1 |
1.3K |
1 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
1
|
1.3K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
tinyteddy
|
161 |
54K |
2 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
161
|
54K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
tinyteddy
|
161 |
54K |
0 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
161
|
54K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
tinyteddy
|
161 |
54K |
0 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
161
|
54K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
tinyteddy
|
161 |
54K |
0 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
161
|
54K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Encouraging Interim Clinical Trial Results
|
|
tinyteddy
|
13 |
5.5K |
9 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
13
|
5.5K
|
9
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine Trial and Forward Plans
|
|
tinyteddy
|
29 |
9.2K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
29
|
9.2K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer to raise up to $9.9 million
|
|
tinyteddy
|
161 |
54K |
3 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
161
|
54K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
tinyteddy
|
62 |
17K |
1 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
62
|
17K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Pancreatic Cancer in the Media
|
|
tinyteddy
|
62 |
17K |
0 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
62
|
17K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Mr Brian Leedman to retire from the Board of OncoSil
|
|
tinyteddy
|
14 |
5.2K |
1 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
14
|
5.2K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
News: FRE Firebrick Pharma Requests Trading Halt
|
|
tinyteddy
|
12 |
4.2K |
5 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
12
|
4.2K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
tinyteddy
|
31 |
12K |
1 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
31
|
12K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
tinyteddy
|
31 |
12K |
1 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
31
|
12K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
tinyteddy
|
31 |
12K |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
31
|
12K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
tinyteddy
|
31 |
12K |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
31
|
12K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
key dates??
|
|
tinyteddy
|
16 |
4.5K |
4 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
16
|
4.5K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
tinyteddy
|
31 |
12K |
0 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
31
|
12K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Appointment of Director - Dr Russell Basser
|
|
tinyteddy
|
2 |
1.0K |
2 |
03/09/23 |
03/09/23 |
ASX - By Stock
|
2
|
1.0K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
tinyteddy
|
31 |
12K |
1 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
31
|
12K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Ann: MVP Announces FY23 Full Year Results
|
|
tinyteddy
|
17 |
6.8K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
17
|
6.8K
|
2
|
|
ASX - By Stock
|
NHC |
Re:
Acland Mine Approval
|
|
tinyteddy
|
300 |
127K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
300
|
127K
|
0
|
|
ASX - By Stock
|
PBP |
Re:
Ann: FY23 Results Presentation
|
|
tinyteddy
|
4 |
2.7K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
4
|
2.7K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Patient Demand
|
|
tinyteddy
|
5 |
3.6K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
5
|
3.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
tinyteddy
|
50 |
14K |
1 |
27/08/23 |
27/08/23 |
ASX - By Stock
|
50
|
14K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
tinyteddy
|
50 |
14K |
0 |
27/08/23 |
27/08/23 |
ASX - By Stock
|
50
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
tinyteddy
|
50 |
14K |
1 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
50
|
14K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
tinyteddy
|
50 |
14K |
0 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
50
|
14K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
After approval
|
|
tinyteddy
|
22 |
5.2K |
1 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
22
|
5.2K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
tinyteddy
|
50 |
14K |
1 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
50
|
14K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
After approval
|
|
tinyteddy
|
22 |
5.2K |
2 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
22
|
5.2K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
tinyteddy
|
50 |
14K |
4 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
50
|
14K
|
4
|
|
ASX - By Stock
|
D2O |
Re:
Ann: Monthly Update - July 2023
|
|
tinyteddy
|
7 |
3.9K |
1 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
7
|
3.9K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of principal place of business
|
|
tinyteddy
|
50 |
14K |
1 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
50
|
14K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid - Vaccine - Viraleze
|
|
tinyteddy
|
215 |
58K |
1 |
19/08/23 |
19/08/23 |
ASX - By Stock
|
215
|
58K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
0 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
37
|
13K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Just a quick comment.....
|
|
tinyteddy
|
11 |
4.2K |
3 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
11
|
4.2K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
4 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
37
|
13K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
tinyteddy
|
25 |
8.5K |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
25
|
8.5K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
3 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
37
|
13K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
37
|
13K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
1 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
37
|
13K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
37
|
13K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
37
|
13K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil
|
|
tinyteddy
|
37 |
13K |
0 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
37
|
13K
|
0
|
|